Alternatives to Lialda If You Can't Fill Your Prescription

If your pharmacy can't fill your Lialda prescription — whether due to local stock issues, insurance coverage problems, or cost — you're not without options. There are several effective alternatives for managing ulcerative colitis, ranging from other mesalamine formulations to different drug classes entirely. This guide walks through the most commonly used substitutes, their key differences, and what to discuss with your doctor.

Important: Never switch or stop your UC medication without consulting your doctor first. Ulcerative colitis is a serious condition, and the wrong substitution — or a gap in treatment — can trigger a flare.

Option 1: Generic Mesalamine DR Tablets (Best First Choice)

The easiest and most seamless alternative to brand-name Lialda is generic mesalamine 1.2 g delayed-release tablets. These are FDA-approved bioequivalents manufactured by companies like Zydus Pharmaceuticals and Camber Pharmaceuticals. They contain the same active ingredient at the same dose and use the same delayed-release mechanism to deliver mesalamine to the colon.

Cost savings are significant: generic mesalamine DR can cost as low as $45 per month with a GoodRx coupon, compared to $1,100+ for brand Lialda. Most pharmacies stock the generic even when Lialda brand is unavailable. This is the first thing to ask about when you can't find Lialda.

Option 2: Apriso (Mesalamine Extended-Release Capsules, 0.375 g)

Apriso is another once-daily mesalamine option, but it comes in extended-release capsules (0.375 g) rather than delayed-release tablets. It is FDA-approved only for the maintenance of remission of UC in adults — not for induction. The daily maintenance dose is 1.5 g (four capsules once daily in the morning). Apriso can be taken with or without food.

Key difference from Lialda: Apriso releases mesalamine throughout the GI tract via a different mechanism (Intellicor technology), while Lialda uses MMX technology to target the colon. They are NOT directly interchangeable without a new prescription, as the formulations and indications differ.

Option 3: Delzicol (Mesalamine Delayed-Release Capsules, 400 mg)

Delzicol contains 400 mg of mesalamine in delayed-release capsules. For induction, the typical dose is 800 mg (two capsules) three times daily for 6 weeks. For maintenance, it's 800 mg twice daily or 400 mg four times daily. This means more pills per day compared to Lialda's once-daily dosing, which may affect adherence.

Delzicol is FDA-approved for induction and maintenance in adults and can be used in children 5+ years old in specific weight ranges. It can be taken with or without food. Generic delayed-release mesalamine capsules (400 mg) are available.

Option 4: Pentasa (Mesalamine Extended-Release Capsules, 250 mg/500 mg)

Pentasa is an extended-release mesalamine capsule that releases the drug throughout the entire GI tract — from the small intestine through the colon. This makes it useful for patients with disease involvement in both the small bowel and colon, unlike Lialda which targets primarily the colon. The typical induction dose is 1 g (four 250-mg capsules or two 500-mg capsules) four times daily.

Pentasa requires multiple daily doses, which is less convenient than Lialda but may be preferable for patients with proximal disease involvement. Generic mesalamine ER capsules are available.

Option 5: Asacol HD (Mesalamine Delayed-Release Tablets, 800 mg)

Asacol HD contains 800 mg mesalamine delayed-release tablets, taken three times daily for induction (total 2.4 g/day). It uses a different coating (Eudragit S) that releases in the terminal ileum, similar to Lialda. It is FDA-approved for adults only. Generic 800 mg mesalamine DR tablets are available.

Option 6: Sulfasalazine (Azulfidine)

Sulfasalazine was the original first-line treatment for UC before mesalamine products existed. It's a combination of mesalamine and sulfapyridine (an antibiotic component). It's effective but has more side effects than pure mesalamine products — particularly for patients with sulfa allergies or those who develop GI intolerance. It's inexpensive and widely available, and may be an option in cost-sensitive situations.

When Are Stronger Medications Needed?

5-ASA medications like Lialda are first-line therapies for mild to moderate UC. If your disease is moderate to severe, or if 5-ASAs haven't controlled your symptoms, your gastroenterologist may recommend stepping up to:

• Corticosteroids (prednisone, budesonide) — short-term use to get a flare under control
• Immunomodulators (azathioprine, 6-mercaptopurine) — long-term maintenance for steroid-dependent patients
• Biologics (infliximab/Remicade, adalimumab/Humira, vedolizumab/Entyvio, ustekinumab/Stelara) — targeted therapies for moderate-severe UC
• JAK inhibitors (tofacitinib/Xeljanz, upadacitinib/Rinvoq) — oral options for moderate-severe UC

Comparison at a Glance

Here's a quick summary of the main 5-ASA alternatives to Lialda:

• Generic Mesalamine DR (1.2 g tablets): Identical to Lialda, once daily, widely available, lowest cost option
• Apriso (0.375 g ER capsules): Once daily, maintenance only, adults only
• Delzicol (400 mg DR capsules): Multiple daily doses, induction and maintenance, adults and children 5+
• Pentasa (500 mg ER capsules): Multiple daily doses, covers entire GI tract, useful for small bowel involvement
• Asacol HD (800 mg DR tablets): 3x daily dosing, adults only, induction and maintenance

The Bottom Line

If you can't fill your Lialda prescription, the most likely solution is simply switching to generic mesalamine 1.2 g delayed-release tablets — the same drug at a fraction of the cost. For patients who genuinely can't access any mesalamine formulation, other 5-ASA options are available. Use medfinder to find which pharmacies near you can fill your prescription today, and don't wait too long before contacting your doctor if you're running out.